| Dermatological and Skeletal Disorders | Lifetime | 2 | IT 1 | 99.76 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 6 | IT 1 | 99.84 |
| Peptidase Inhibition and Analysis | Lifetime | 75 | IT 3 | 99.62 |
| Multiple Myeloma Research and Treatments | Lifetime | 63 | IT 4 | 99.53 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 143 | IT 12 | 99.54 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 65 | IT 7 | 99.09 |
| Parathyroid Disorders and Treatments | Lifetime | 112 | IT 5 | 99.07 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 106 | IT 17 | 99.07 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 111 | IT 2 | 99.09 |
| Neuroendocrine Tumor Research Advances | Lifetime | 257 | IT 31 | 98.94 |
| Drug Transport and Resistance Mechanisms | Lifetime | 299 | IT 6 | 98.50 |
| Pancreatitis Pathology and Treatment | Lifetime | 292 | IT 24 | 98.47 |
| Eosinophilic Disorders and Syndromes | Lifetime | 187 | IT 21 | 98.42 |
| Alzheimer's disease research and treatments | Lifetime | 560 | IT 16 | 98.62 |
| Pneumocystis jirovecii pneumonia detection and treatment | Lifetime | 490 | IT 30 | 97.54 |
| Chronic Myeloid Leukemia Treatments | Lifetime | 704 | IT 72 | 97.03 |
| Sarcoidosis and Beryllium Toxicity Research | Lifetime | 551 | IT 37 | 93.43 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 276 | IT 19 | 92.17 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 12 | IT 4 | 99.31 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 287 | IT 17 | 96.91 |
| Parathyroid Disorders and Treatments | 2021-2025 | 144 | IT 25 | 94.75 |
| Chronic Myeloid Leukemia Treatments | 2021-2025 | 294 | IT 35 | 94.87 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 213 | IT 24 | 90.75 |
| Peptidase Inhibition and Analysis | 2021-2025 | 742 | IT 41 | 88.30 |
| Multiple Myeloma Research and Treatments | 2021-2025 | 813 | IT 48 | 89.48 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 373 | IT 35 | 84.15 |
| Protein Kinase Regulation and GTPase Signaling | 2021-2025 | 336 | IT 12 | 64.43 |
| Dermatological and Skeletal Disorders | 2021-2025 | 320 | IT 57 | 64.25 |
